Clinical Trial Update: The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease [NA]

View source ↗

Summary

A clinical trial update indicates recruitment is ongoing for a study evaluating the probiotic Clostridium butyricum Miyairisan for motor and non-motor symptoms …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Clostridium butyricum Miyairisan (Clostridium butyricum)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Clostridium Butyricum Miyairi, Parkinson Disease | NA | Status: RECRUITING